About
QunaSys is a Japanese quantum software company founded in 2018 that specializes in quantum chemistry software and molecular simulation. It develops quantum algorithms and computational tools for chemical and pharmaceutical research, materials science, and drug discovery, providing platforms that use quantum computing to address molecular and chemical problems that are difficult for classical computers. Its customers are research institutions and companies in Japan and worldwide. QunaSys raised $29.7M from Global Brain, JIC Venture Growth, Mitsubishi Electric, and Zeon Corporation. It launched the QSCI Technical Portal and an official partner program, licensing its quantum-enhanced molecular simulation platform to pharmaceutical companies to speed up drug discovery. Commercial partners include Biogen, Dow Chemical, and Accenture. The company's QSCI (Quantum-Selected Configuration Interaction) algorithm is being extended beyond quantum chemistry into optimization problems. Update 2026-03-03: QunaSys launched a technical portal and partner program to support the commercial deployment of its Quantum-Selected Configuration Interaction algorithm. Source: https://quantumzeitgeist.com/qunasys-quantum-computing-algorithms/
Quantum Specifications
| Quantum Focus | software |
Backed By
Frequently Asked Questions
Related News
RIKEN will use QunaSys software to link supercomputer with quantum chips
RIKEN Integrates QunaSys QURI SDK Enterprise into Japan’s JHPC-quantum Platform
RIKEN Adopts QunaSys QURI SDK for Quantum-HPC Hybrid Computing
Qunasys Inc Team Models Nonlinear Fluid Dynamics for Quantum Simulation
